… responses against SARS-CoV-2, cell-based immunotherapies have been recently introduced as new treatmentoptions for SARS-CoV-2. The cell-based immunotherapies include the …
… proposed for the prevention and treatment of COVID-19 patients. In fact, and a number of clinical trials have recently reported its therapeutic value in COVID-19. However, low affinity or …
HF Florindo, R Kleiner, D Vaskovich-Koubi… - Nature …, 2020 - nature.com
… COVID-19 in Japan 19 . In the rest of the world, there are no specific treatments or vaccines available for COVID-19… To the best of our knowledge, the only available options are the …
A Teimury, E Mahmoodi Khaledi - Risk Management and …, 2020 - Taylor & Francis
… -19 patients. In this review, we collected information about the most widely used drugs … treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune …
F Wang, H Hou, Y Luo, G Tang, S Wu, M Huang, W Liu… - JCI insight, 2020 - ncbi.nlm.nih.gov
… immunity. The methods that can be used to predict the development of severe illness are of great value for treatment and prognosis of SARS-CoV-2 infection. The establishment of these …
… to the sufficient health-care services will increase. There is currently no specific treatment and effective vaccine for COVID-19. The novel coronavirus pandemic is more consistent with …
AG Laing, A Lorenc, I Del Molino Del Barrio, A Das… - Nature medicine, 2020 - nature.com
… COVID-19 cohorts, individual traits within this signature may collectively and individually guide treatmentoptions; offer insights into COVID-19 … in phasic diseases such as COVID-19. …
G Widjaja, AT Jalil, HS Rahman, WK Abdelbasset… - Human Immunology, 2021 - Elsevier
… The great demand for the discovery of primary care-based therapeuticmethods that combine the high specificity and accelerated development to control a serious viral outbreak often …
… in the prevention of severe COVID-19 is limited by the use of different methods to identify and … Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic …